查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701348

听力损失治疗市场规模、份额、趋势分析报告：按产品、疾病、最终用途、地区、细分市场预测，2025-2030 年

Hearing Loss Disease Treatment Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Disease (Conductive, Sensorineural), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

听力损失治疗市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球听力损失治疗市场规模预计到2030年将达到175.1亿美元，2025年至2030年期间的复合年增长率为7.29%。

这种增长的推动因素包括全球疾病负担的增加、政府和私人组织为提高意识所做的努力以及世界老年人口的不断增长。此外，临床研发药物数量的增加和助听设备的进步为该行业的发展提供了有利的机会。全球听力损失的盛行率正在上升，这是推动该行业成长的主要因素。

例如，世界卫生组织报告称，到2021年，全球将有超过5%的人口（约4.3亿人）需要復健治疗来控制听力损失。此外，预计到2050年，全球约有25亿人将受到听力损失的影响。报告称，中低收入国家占残障人口的80%。老化进一步加剧了盛行率的上升。在全球整体，大约有25%的60岁以上的老人患有听力损失。因此，疾病的增加透过增加治疗需求来推动该行业的发展。该领域存在强大的临床试验管道，预计在未来几年提供更好的治疗选择。

这是由于目前有超过 45 种治疗方法处于不同阶段的临床试验。例如，Sound Pharmaceuticals 的 Ebselen 和 Sensorion 的 SENS-401 分别处于治疗梅尼尔氏症和感音性听障的 3 期临床试验阶段。同样，2022 年 6 月，Pipeline Therapeutics 的 2 期研究药物 PIPE-505 正在接受感音性听障的评估。因此，未来几年新治疗方案的推出预计将为该行业提供丰厚的机会。不断涌现的技术进步，例如听力产品中与人工智慧相关的创新，正在推动该行业的发展。

推出具有智慧型手机操作、可充电和防水设备等先进功能的产品正在提升客户体验。例如，2022 年 6 月，GN Hearing 推出了“Custom made by Resound”，这是一款可充电助听器，支援 Android 和 iOS 的无线串流播放。主要企业正在采取新产品发布、合作伙伴关係、协议和金融投资等策略性倡议，进一步推动产业发展。例如，2022 年 4 月，Autigen 与勃林格殷格翰达成研究合作和授权合约，为患有感音神经疾病的患者开发先进的治疗方法。同样，2022 年 9 月，Fennec Pharmaceuticals 宣布 FDA核准Pedmarkto 用于预防接受化疗的儿科患者的听力损失。

听力损失治疗市场报告重点：

  • 2024年，设备部门占据产业主导地位，占总收益的最大份额，超过91.02％。这是由于设备技术的进步、其普及率高以及设备效益的不断提高。
  • 由于新治疗产品的推出，预计预测期内製药业将实现最快的复合年增长率。有多种类型的听力损失可以使用药物治疗。
  • 预计到 2024 年，感音性听障领域将占据行业主导地位，占总收入的最大份额，超过 65.24%，并且预计将成为预测期内增长最快的领域。
  • 2024年，北美听力损失治疗产业占据全球主导地位，占全球份额的31.32%。

目录

第一章调查方法与范围

第二章执行摘要

第三章听力损​​失治疗市场变数、趋势和范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 社会耻辱的存在
  • 中低收入国家（LMIC）的报销制度不足
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
    • 管道分析

第四章听力损失治疗市场：按产品分類的业务分析

  • 2024 年及 2030 年产品市场占有率
  • 产品细分仪表板
  • 市场规模、预测与趋势分析（按产品，2018-2030 年）
  • 装置
  • 药物

第五章听力损失治疗市场：依疾病的商业分析

  • 2024年及2030年的疾病市场占有率
  • 疾病细分仪表板
  • 市场规模、预测与趋势分析（按疾病，2018-2030 年）
  • 传导性听力损失
  • 感觉神经性听力损失
  • 混合型（传导性和感音神经性）

第六章听力损失治疗市场：最终使用者的商业分析

  • 2024 年及 2030 年最终用户市场占有率
  • 最终用户细分仪表板
  • 按最终用途分類的市场规模、预测和趋势分析（2018-2030 年）
  • 医院
  • 耳鼻喉诊所
  • 门诊

第七章听力损失治疗市场：区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018年至2030年市场规模与预测趋势分析：
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/列表
    • Novartis AG
    • Spiral Therapeutics（Otonomy, Inc.）
    • Acousia Therapeutics Gmbh
    • Sensorion
    • Audina Hearing Instruments, Inc.
    • Ws Audiology A/S
    • audifon Gmbh &Co. Kg
    • MED-EL Medical Electronics
    • Demant A/S
    • Sonova
Product Code: GVR-4-68040-019-9

Hearing Loss Disease Treatment Market Growth & Trends:

The global hearing loss disease treatment market size is expected to reach USD 17.51 billion by 2030, registering a CAGR of 7.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world's population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals' Ebselen and Sensorion's SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere's Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics' phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

Hearing Loss Disease Treatment Market Report Highlights:

  • The devices segment dominated the industry in 2024 and accounted for the maximum share of more than 91.02% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
  • The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
  • The sensorineural hearing loss segment dominated the industry in 2024 and accounted for the maximum share of more than 65.24% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
  • North America hearing loss disease treatment industry held the leading position in 2024, accounting for 31.32% of the global share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease
    • 1.2.3. End User
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hearing Loss Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in the number of patients with hearing loss
      • 3.2.1.2. Strong research and development pipeline
      • 3.2.1.3. Technological advancements in hearing aids
    • 3.2.2. Market Restraint Analysis
  • 3.3. 3.3.1 Presence of social stigmas
  • 3.4. 3.3.2 Poor reimbursement facilities in low- and middle-income countries (LMICs)
  • 3.5. Business Environment Analysis
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier Power
      • 3.5.1.2. Buyer Power
      • 3.5.1.3. Substitution Threat
      • 3.5.1.4. Threat of New Entrants
      • 3.5.1.5. Competitive Rivalry
    • 3.5.2. PESTLE Analysis
    • 3.5.3. Pipeline Analysis

Chapter 4. Hearing Loss Disease Treatment Market: Products Business Analysis

  • 4.1. Products Market Share, 2024 & 2030
  • 4.2. Products Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Products, 2018 to 2030 (USD Million)
  • 4.4. Devices
    • 4.4.1. Devices Market, 2018 - 2030 (USD Million)
  • 4.5. Drugs
    • 4.5.1. Drugs Market, 2018 - 2030 (USD Million)
    • 4.5.2. Systemic steroids
      • 4.5.2.1. Systemic steroids Market, 2018 - 2030 (USD Million)
    • 4.5.3. Antiviral medication
      • 4.5.3.1. Antiviral medication Market, 2018 - 2030 (USD Million)
    • 4.5.4. Vasodilators
      • 4.5.4.1. Vasodilators Market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Hearing Loss Disease Treatment Market: Disease Business Analysis

  • 5.1. Disease Market Share, 2024 & 2030
  • 5.2. Disease Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease, 2018 to 2030 (USD Million)
  • 5.4. Conductive Hearing Loss
    • 5.4.1. Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
  • 5.5. Sensorineural Hearing Loss
    • 5.5.1. Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
  • 5.6. Mixed (Conductive and Sensorineural)
    • 5.6.1. Mixed (Conductive and Sensorineural) Market, 2018 - 2030 (USD Million)

Chapter 6. Hearing Loss Disease Treatment Market: End User Business Analysis

  • 6.1. End User Market Share, 2024 & 2030
  • 6.2. End User Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End User, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Otology clinics
    • 6.5.1. Otology clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory clinics
    • 6.6.1. Ambulatory clinics Market, 2018 - 2030 (USD Million)

Chapter 7. Hearing Loss Disease Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Hearing Loss Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. U.S. Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. UK Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Target Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Target Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Target Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Target Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Target Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Target Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Japan Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Target Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. China Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Target Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Target Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Target Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Target Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Hearing Loss Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Novartis AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Spiral Therapeutics (Otonomy, Inc.)
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Acousia Therapeutics Gmbh
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Sensorion
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Audina Hearing Instruments, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Ws Audiology A/S
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. audifon Gmbh & Co. Kg
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. MED-EL Medical Electronics
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Demant A/S
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Sonova
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Hearing Loss Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 7 Global Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 8 Global Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 North America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 12 North America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 15 U.S. Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Canada Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 Canada Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Canada Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Mexico Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 Mexico Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 21 Mexico Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Europe Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Europe Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 25 Europe Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Germany Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 28 Germany Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 UK Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 UK Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 UK Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 France Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 France Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 34 France Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Italy Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 Italy Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 37 Italy Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Spain Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Spain Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 Spain Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Denmark Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Denmark Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Denmark Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Sweden Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Sweden Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Sweden Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Norway Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Norway Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 49 Norway Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Japan Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Japan Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 China Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 China Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 China Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 India Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 India Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 62 India Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 South Korea Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 South Korea Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 South Korea Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Australia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Australia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 68 Australia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Thailand Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 70 Thailand Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 71 Thailand Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Latin America Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Latin America Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 74 Latin America Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 75 Latin America Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 76 Brazil Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Brazil Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 78 Brazil Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Argentina Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Argentina Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 81 Argentina Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Hearing Loss Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 89 South Africa Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 90 South Africa Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 91 South Africa Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 92 UAE Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 UAE Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 94 UAE Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Hearing Loss Disease Treatment Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Hearing Loss Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Hearing Loss Disease Treatment Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market summary
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Hearing Loss Disease Treatment Market - PESTLE Analysis
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Hearing Loss Disease Treatment Market Outlook Key Takeaways
  • Fig. 16 Hearing Loss Disease Treatment Market: Product Movement Analysis
  • Fig. 17 Global Hearing Loss Disease Treatment Market, by Product, 2018 - 2030 (USD Million)
  • Fig. 18 Global Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Devices Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Systemic Steroids Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Antiviral Medication Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Vasodilators Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Hearing Loss Disease Treatment Market: Disease Movement Analysis
  • Fig. 25 Global Hearing Loss Disease Treatment Market, by Disease, 2018 - 2030 (USD Million)
  • Fig. 26 Global Conductive Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Sensorineural Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Mixed Hearing Loss Market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Hearing Loss Disease Treatment Market: End-User Movement Analysis
  • Fig. 30 Global Hearing Loss Disease Treatment Market, by End-User, 2018 - 2030 (USD Million)
  • Fig. 31 Global Otology Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Ambulatory Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Market: Key Takeaways
  • Fig. 35 Hearing Loss Disease Treatment Market Regional Outlook, 2018 & 2030
  • Fig. 36 North America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East & Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Hearing Loss Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 64 Strategy Frameworks